Integrase Inhibitor (MK-0518) Viral Decay

NCT00520897 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Raltegravir (MK0518)
DRUG: Placebo
PROCEDURE: Leukopheresis
PROCEDURE: Sigmoid Biopsy

Sponsor

Canadian Immunodeficiency Research Collaborative

Collaborators

[object Object]